Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations

Figure 2

Tissue microarray-based immunohistochemical analyses of TRAIL receptors TRAIL-R1 and TRAIL-R2 in CRC carcinogenesis. A progressive increase on TRAIL-R1 expression was seen from normal colorectal mucosa (A) to adenoma (B) to carcinoma(C). Similarly, a progressive increase on TRAIL-R2 expression was seen from normal colorectal mucosa (D) to adenoma (E) to carcinoma (F).

Back to article page